Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 243

Cannabinoids Data Safety Patients 243

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. Phase 2 trial underway.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Parkinson’s disease and cannabis. Interest among patients is high, but knowledge is limited.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021).

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Eight studies were included, all of which are randomized controlled trials.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study abstract is available here. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 96

Medicine Treatment Patients Data 96

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

NORML

MARCH 23, 2020

The National Organization for the Reform of Marijuana Laws wishes to reiterate its message that cannabis consumers and others beware of online misinformation surrounding the use of either whole-plant cannabis or CBD as a potential remedy for the COVID-19 virus. Some of these marketers are explicitly targeting cannabis consumers.

CBD 349

CBD Therapy Treatment Packaging 349

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

AUGUST 5, 2019

PUBLISHER: CANNABIS LAW REPORT. France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug. Patients with muscle spasms related to multiple sclerosis are also invited to take part. AUTHOR: Mark Taylor. million use it on a regular basis.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 93

Research and Development Consumption Education Data 93

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. Some of the outcomes we’re interested in looking at, is what kind of cannabis are they using?

Medicine 140

Medicine Research and Development Data Collective 140

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. What is Artisanal CBD?

Epilepsy 58

Epilepsy Pharmaceutical Patients Sleep 58

Cannabis Law Report

NOVEMBER 17, 2021

A Melbourne doctor who is fighting for permission to treat a severely unwell patient with the drug MDMA has taken his battle to court, in what is believed to be the first case of its kind in Australia. Key points: A lawyer representing Dr Kotler says the psychiatrist believes using the drug would safely help his patient.

Patients 52

Patients Data Safety Medicine 52

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. This latest partnership further strengthens Beckley Psytech’s digital strategy to develop personalised, end-to-end treatment programmes for patients in areas of significant unmet medical need.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

NOVEMBER 18, 2022

A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Earlier this month, we reported on the pair’s unexpected venture into the world of cannabis! Let’s dive into this week’s cannanews.

Edibles 86

Edibles Hemp Epilepsy Programs 86

Cannabis Law Report

JUNE 18, 2021

Crash rates spiked with the legalization of recreational marijuana use and retail sales in California, Colorado, Nevada, Oregon and Washington, a new study by the Insurance Institute for Highway Safety (IIHS) and another by the affiliated Highway Loss Data Institute (HLDI) show. Insurance Institute for Highway Safety.

Safety 66

Safety Legalization Marijuana Retail 66

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

AUGUST 3, 2021

On Wednesday, June 30, Governor Tom Wolf (D) of Pennsylvania signed medical cannabis legislation amendments into effect. The newly signed legal framework will boost medical cannabis purchase limits, as well as prolong specific policies that were imposed on a temporary basis when the coronavirus (COVID-19) health crisis initially erupted.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

SEPTEMBER 1, 2021

WORCESTER —On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales , according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today. Of those, 35.4

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JUNE 17, 2022

Members of the DC City Council recently voted 13 to zero to advance legislation, the Cannabis Employment Protections Amendment Act of 2022 , protecting those who use cannabis from facing discrimination in the workplace. status as a medical cannabis program patient,” or.

Safety 52

Safety Legislation Policy Cannabis 52

Veriheal

DECEMBER 23, 2022

Cannabis prohibition is doing more than just creating a barricade between consumers and safe products. State Cannabis Contaminant Rules Vary Widely,” consumers have little choice but to purchase contaminated cannabis products. Researchers Inspected Cannabis Products for Contaminants. Led by Dr. Maxwell C.K.

Research and Development 77

Research and Development Agriculture Data Extraction 77

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. ” Dr. Gallow prides himself on his work as a South African cannabis advocate and leader in the international medical cannabis research field. It has been fairly slow,” explained Dr. Gallow.

Clinical Trials 111

Clinical Trials Chronic Pain Hydroponic Strains 111

Cannabis Law Report

SEPTEMBER 11, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Around 90% of participants self-medicated with cannabis daily. There were also no variations in QoL.

Patients 49

Patients Marijuana Epilepsy Treatment 49

NORML

SEPTEMBER 27, 2019

Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. California NORML’s fact-sheet, “Cannabis Vaping: What’s Safe and What’s Not,” is online here.

Vaping 209

Vaping Data Retail THC 209

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

The Cannigma

OCTOBER 21, 2021

ADHD has long been tied to increased cannabis use, as well as abuse of drugs like alcohol and nicotine. Still, many patients report that cannabis helps them to feel more in control of their symptoms, leading to important questions. Can cannabis help with ADHD? Can cannabis help with ADHD? What is ADHD? 6 7 8 9.

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

TheAnswerPage

JULY 17, 2022

The analysis attempted to establish the safety and efficacy of the CBD products, and to determine if there is enough evidence to assume any difference in efficacy between CBD-rich extracts compared to purified CBD products. Two thirds of patients reported improvement in the frequency of seizures (399/622, 64%). 12 September 2018.

Epilepsy 72

Epilepsy Extraction Treatment CBD 72